1. Academic Validation
  2. Susceptibilities of human cytomegalovirus clinical isolates to BAY38-4766, BAY43-9695, and ganciclovir

Susceptibilities of human cytomegalovirus clinical isolates to BAY38-4766, BAY43-9695, and ganciclovir

  • Antimicrob Agents Chemother. 2001 Oct;45(10):2925-7. doi: 10.1128/AAC.45.10.2925-2927.2001.
J J McSharry 1 A McDonough B Olson S Hallenberger J Reefschlaeger W Bender G L Drusano
Affiliations

Affiliation

  • 1 Center for Immunology and Microbial Diseases, Albany Medical College, 47 New Scotland Ave., Albany, NY 12208, USA. mcsharj@mail.amc.edu
Abstract

BAY38-4766 and BAY43-9695 are nonnucleosidic compounds with activities against human cytomegalovirus (HCMV). Two phenotypic assays were used to determine the drug susceptibilities of 36 HCMV clinical isolates to the BAY compounds and ganciclovir. Using either assay, both BAY compounds at a concentration of approximately 1 microM inhibited the replication of all 36 HCMV clinical isolates, including 11 ganciclovir-resistant clinical isolates, by 50%.

Figures
Products
我们的 Cookie 政策

我们使用 Cookies 和类似技术以提高网站的性能和提升您的浏览体验,部分功能也使用 Cookies 帮助我们更好地理解您的需求,为您提供相关的服务。 如果您有任何关于我们如何处理您个人信息的疑问,请阅读我们的《隐私声明》